I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Rationale and design of the 2 by 2 factorial design GnG-tri..:
Sonia Jaramillo
;
Johannes Krisam
;
Lucian Le Cornet
...
https://doi.org/10.1186/s13063-021-05703-w. , 2021
Link:
https://doi.org/10.1186/s13063-021-05703-w
RT Journal T1
Rationale and design of the 2 by 2 factorial design GnG-trial: a randomized phase-III study to compare two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and to compare double-blinded intensive postremission therapy with or without glasdegib in older patients with newly diagnosed AML
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:de39e7989b1540d2a1eb5143a0cffc57&Exemplar=1&LAN=DE A1 Sonia Jaramillo A1 Johannes Krisam A1 Lucian Le Cornet A1 Markus Kratzmann A1 Lukas Baumann A1 Tim Sauer A1 Martina Crysandt A1 Andreas Rank A1 Dirk Behringer A1 Lino Teichmann A1 Martin Görner A1 Ralf-Ulrich Trappe A1 Christoph Röllig A1 Stefan Krause A1 Maher Hanoun A1 Olaf Hopfer A1 Gerhard Held A1 Sebastian Buske A1 Lars Fransecky A1 Sabine Kayser A1 Christoph Schliemann A1 Kerstin Schaefer-Eckart A1 Yousef Al-Fareh A1 Jörg Schubert A1 Thomas Geer A1 Martin Kaufmann A1 Arne Brecht A1 Dirk Niemann A1 Meinhard Kieser A1 Martin Bornhäuser A1 Uwe Platzbecker A1 Hubert Serve A1 Claudia D. Baldus A1 Carsten Müller-Tidow A1 Richard F. Schlenk PB BMC YR 2021 K1 gemtuzumab ozogamicin K1 glasdegib K1 acute myeloid leukemia K1 measurable residual disease K1 Medicine (General) K1 R5-920 JF https://doi.org/10.1186/s13063-021-05703-w LK http://dx.doi.org/https://doi.org/10.1186/s13063-021-05703-w DO https://doi.org/10.1186/s13063-021-05703-w SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)